Medicare Part D 2008 Data Spotlight: Utilization Management January 2, 2008 Issue Brief This Medicare Part D data spotlight examines three common techniques used by Medicare stand-alone prescription drug plans in 2008 to manage enrollees’ use of formulary drugs, such as quantity limits, prior authorization, and step therapy rules. This is one in a series analyzing key aspects of the 2008 Medicare Part…
Medicare Part D 2008 Data Spotlight: Benefit Design November 30, 2007 Issue Brief This Medicare Part D data spotlight examines the benefit design of Medicare Part D Prescription Drug Plans (PDP) in 2008, focusing on national plans. It shows that in 2008, as in previous years, only about 10 percent of national prescription drug plans offered the defined standard benefit. The spotlight also…
Medicare Part D 2008 Data Spotlights November 30, 2007 Issue Brief To better understand changes in the private plans providing drug coverage to Medicare beneficiaries under the program's Part D benefit, the Kaiser Family Foundation is issuing a series of data spotlights analyzing key elements of Medicare's private drug plans. Each spotlight will focus on a key aspect of the drug…
Medicare Part D 2008 Data Spotlight: Specialty Tiers November 30, 2007 Issue Brief This Medicare Part D data spotlight focuses on the use of specialty tiers for high-cost and injectible drugs in Medicare Prescription Drug Plans in 2008. It finds that the number of plans with specialty tiers has nearly doubled since 2006. It also looks at the drugs assigned to specialty tiers,…
Medicare Part D 2008 Data Spotlight: The Coverage Gap October 30, 2007 Issue Brief This Medicare Part D data spotlight examines the coverage gap, or “doughnut hole,” in Medicare drug plans available in 2008. Part D enrollees (other than those receiving low-income subsidies) will reach the coverage gap after they incur $2,510 in total drug costs in 2008. At that point, enrollees are required…
Medicare Part D 2008 Data Spotlight: Premiums October 30, 2007 Issue Brief This Medicare Part D data spotlight analyzes the premiums charged by the 1,824 stand-alone Medicare Part D plans that will be offered in markets across the country in 2008. The analysis finds premiums charged for Part D plans range widely, from $9.80 per month to $107.50 per month. The average…
Overview of Medicare Part D Organizations, Plans and Benefits By Enrollment in 2006 and 2007 October 30, 2007 Report This chartpack provides detailed information about Medicare beneficiaries’ enrollment in the many private drug plans available to them in 2007. The charts demonstrate that a relatively small number of companies which captured the most enrollees in 2006, the new benefit’s first year, continued to lead in market share in the…
Findings from the Kaiser/Commonwealth/Tufts-New England Medical Center 2006 National Survey of Seniors and Prescription Drugs – Chartpack August 1, 2007 Report This chartpack contains key data from the Kaiser/Commonwealth/Tufts-New England Medical Center 2006 National Survey of Seniors and Prescription Drugs. Findings of the survey were published in a Health Affairs Web Exclusive on Aug. 21, 2007. Chartpack (.pdf)
Medicare Prescription Drug Benefit Progress Report: Findings From A 2006 National Survey of Seniors August 1, 2007 Event The share of seniors without drug coverage dropped significantly under Medicare’s new drug benefit, according to this August 2007 Health Affairs Web Exclusive article based on a Kaiser Family Foundation, Commonwealth Fund and Tufts-New England Medical Center survey of more than 16,000 seniors. Seniors with drug coverage from any source…
The Role of State Pharmaceutical Assistance Programs in Serving Low-Income Medicare Beneficiaries Following the Implementation of Medicare Part D July 2, 2007 Issue Brief The Role of State Pharmaceutical Assistance Programs in Serving Low-Income Medicare Beneficiaries Following the Implementation of Medicare Part DPrior to January 1, 2006, State Pharmaceutical Assistance Programs helped to fill a critical gap in coverage for Medicare beneficiaries without prescription drug coverage, targeting resources to beneficiaries with relatively low incomes.…